Wen Wee Ma, Garth D. Nelson, Nguyen H. Tran, Oxana V. Crysler, Renuka Iyer, Michael Morse, Leslie Washburn, Lionel Aurelien Kankeu Fonkoua, Christos Fountzilas, Mohamad Bassam Sonbol, Anina Peersen, Vaibhav Sahai, Arathi Mohan, Fang-Shu Ou, Tanios S. Bekaii-Saab. "A phase II randomized study of atezolizumab plus multikinase inhibitor (MKI) versus MKI alone in patients with advanced hepatocellular carcinoma previously treated with atezolizumab plus bevacizumab (Atezo/Bev).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.554